Semaglutide Linked to Improved Exercise Capacity, Weight Loss in Patients With HFpEF and Obesity

Patients taking semaglutide for a year saw significant improvements in exercise capacity and lost 2.9% more body weight compared with patients taking placebo.

Related Keywords

Clin Cardiol , ,